Tumor characteristics and survival rate of HER2-low breast cancer patients: a retrospective cohort study

Abstract HER2 is an important prognostic marker in breast cancer (BC) patients, which also plays a crucial role in their therapeutic plan. Consequently, a great desire is to thoroughly assess the patients based on their HER2 status. In the current study, we aimed to evaluate HER2-low breast cancer a...

Full description

Bibliographic Details
Published in:Scientific Reports
Main Authors: Fereshteh Abbasvandi, Mahdis Bayat, Atieh Akbari, Fatemeh Shojaeian, Ashkan Zandi, Jamal Rahmani, Maryam Omrani Hashemi, Mohammad Esmaeil Akbari
Format: Article
Language:English
Published: Nature Portfolio 2023-10-01
Online Access:https://doi.org/10.1038/s41598-023-43186-8

Internet

https://doi.org/10.1038/s41598-023-43186-8

Similar Items